Home > Journals > Medicine > European Journal of Dermatology > Full text
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
European Journal of Dermatology
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
  Printable version

Lichen amyloidosus


European Journal of Dermatology. Volume 9, Number 1, 63-4, January - February 1999, Votre diagnostic ?


Summary  

Author(s) : M. THEWES, R. HEIN, D. RING.

Summary : A 59-year-old man was referred to our clinic in September 1997 with a long history of severe itching on both his lower legs. At clinical examination we found inconspicuous, pruritic eruptions of small brownish macules and papules distributed typically in a rippled, symmetric fashion on the ventral site of the lower leg (Figs. 1 and 2). The remaining integument and all laboratory investigations were normal.

Pictures

ARTICLE

A 59-year-old man was referred to our clinic in September 1997 with a long history of severe itching on both his lower legs. At clinical examination we found inconspicuous, pruritic eruptions of small brownish macules and papules distributed typically in a rippled, symmetric fashion on the ventral site of the lower leg (Figs. 1 and 2). The remaining integument and all laboratory investigations were normal.

Lichen amyloidosus

The term "amyloidosis" was coined because of the deposits of amyloid in organs and includes the systemic and the localized type of cutaneous amyloidosis (LCA). LCA can be subdivided into two groups: the primary and secondary cutaneous forms of amyloidosis. Primary cutaneous amyloidosis type comprises lichen amyloidosus (LA), and the macular and the rare nodular form. Members of the secondary cutaneous forms include sweat gland tumors, pilomatrixoma, dermatofibroma, seborrhoeic keratosis, solar elastosis, actinic keratosis, basal cell carcinoma, Bowen's disease a.o. [1].

In this case, the correct diagnosis of LA was confirmed by histological and histochemical examination of a skin biopsy. On haemalaun-eosin staining, we found deposits which expanded the papillary dermis and displaced the rete ridges laterally (Fig. 3a). Using special stains such as methyl violet staining (Fig. 3b), staining with congo red followed by polarized light microscopy and PAS-staining, we were able to characterize these structures as amyloid. Other useful histochemical stains are included in Table I. The overlying epidermis showed irregular acanthosis and hyperkeratosis, which is a characteristic finding in later lesions.

The pathogenesis of LA is not entirely clear. The most popular hypothesis suggests that because of the severe itching and as a consequence of the scratching there is focal epidermal damage and filamentous degeneration of keratinocytes, followed by apoptosis and conversion of filamentous masses (colloid bodies) into amyloid K (k = keratin) material in the papillary dermis. It has been postulated that in LA, specific immunological tolerance to the presence of colloid bodies in the papillary dermis favors their transformation into amyloid by macrophages and fibroblasts, whereas in lichen planus, for example, a brisk inflammation response ensures their removal. The fact that dermal amyloid K deposits cross-react immunohistochemically with keratin, supports this hypothesis [4, 5]. Recently, Chang et al. [2] reported that EBV may be associated with some cases of LA, but the true aetiological role of EBV in LA remains unknown.

For LA different treatment regimens exist. Systemic antihistamines are effective at reducing the pruritus, which is the important pathophysiological step in LA. As specific therapy, it is possible to use topical steroids, dermabrasion or DMSO [3]. Systemic treatment with etretinate may also be beneficial in some patients, but not in all [1].

REFERENCES

1. Breathnach SM. Amyloid and amyloidosis. J Am Acad Dermatol 1988; 18: 1-16.

2. Chang YT, Liu HN, Wong CK, Chow KC, Chen KY. Detection of Epstein-Barr virus in primary cutaneous amyloidosis. Br J Dermatol 1997; 136: 823-6.

3. Kobayashi T, Yamasaki Y, Watanabe T, Onoda N. Extensive lichen amyloidosus refractory to DMSO. J Dermatol 1995; 22: 755-8.

4. Weyers W, Weyers I, Bonczkowitz M, Diaz-Cascajo C, Schill WB. Lichen amyloidosus: a consequence of scratching. J Am Acad Dermatol 1997; 37: 923-8.

5. Yoneda K, Watanabe H, Yanagihara M, Mori S. Immunohistochemical staining properties of amyloids with anti-keratin antibodies using formalin-fixed, paraffin-embedded sections. J Cutan Pathol 1989; 16: 133-6.


 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]